NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

• David A. Sallman,
• Jason Brayer,
• Elizabeth M. Sagatys,
• Caroline Lonez,
• Eytan Breman,
• Sophie Agaugué,
• Bikash Verma,
• David E. Gilham,
• Frédéric F. Lehmann,
• Marco L Davila

Affiliations

David A. Sallman

Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Jason Brayer

Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Elizabeth M. Sagatys

Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Caroline Lonez

Celyad, SA, Mont-Saint-Guibert, Belgium

Eytan Breman

Celyad, SA, Mont-Saint-Guibert, Belgium

Sophie Agaugué

Celyad, SA, Mont-Saint-Guibert, Belgium

Bikash Verma

Celyad, SA, New York, NY, USA

David E. Gilham

Celyad, SA, Mont-Saint-Guibert, Belgium

Frédéric F. Lehmann

Celyad, SA, Mont-Saint-Guibert, Belgium

Marco L Davila

Blood & Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA